Cirrus Therapeutics
Breakthrough Gene Therapy for Dry AMD
Boston, United States · $11.0M raised
- Headquarters
- Boston, Massachusetts
- Employees
- 1–10
- Business Model
- B2B
- Website
- cirrustx.com
- Total Funding
- $11.0M
- Last Round
- $11.0M SeedOct 2025
- Rounds
- 1
About
Ocular immunology company developing groundbreaking therapies for age-related macular degeneration and other retinal diseases.
Summary
Cirrus Therapeutics is a Biotech company based in Boston, United States. It has raised $11.0M in total across 1 round, most recently a $11.0M Seed round in Oct 2025. Investors include Polaris Partners, ClavystBio and LongGame.
Tech & App Stack
4 technologies & apps tracked
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Oct 2025
Investors
Similar Companies
China's leading blood products manufacturer
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Biopharmaceutical services company
Specialty pharmaceutical company